Predictors for choosing doravirine-based versus INSTI-based regimen in ART-naïve and ART-experienced people with HIV in real-world setting: Data from the Icona cohort

Doravirine (DOR) is an attractive new option both for ART-naïve people with HIV (PWH) and those with suppressed HIV-RNA who seek treatment simplification. We used real-world data to examine the pattern of use of DOR-containing regimens in these settings. All PWH enrolled in the Icona cohort after Ja...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:HIV medicine 2024-12
Hauptverfasser: d'Arminio Monforte, Antonella, Tavelli, Alessandro, Quiros-Roldan, Eugenia, Fabbiani, Massimiliano, Ferrara, Micol, Lo Caputo, Sergio, Squillace, Nicola, Rusconi, Stefano, Ponzano, Marta, Bovis, Francesca, Antinori, Andrea, Saracino, Annalisa, Cozzi-Lepri, Alessandro
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!